biotech · Lung Cancer · Non-small Cell Lung Cancer (NSCLC) · RVMD
Revolution Medicines
Revolution Medicines trial registry — 28 ClinicalTrials.gov studies with program phase, status, and indication context.
700 Saginaw Dr., Redwood City, California 94063, US HQ
2014 Founded
1,050 Employees
Public company Type
RVMD · NYSE Ticker
Company details
- Status
- Public
- HQ
- 700 Saginaw Dr., Redwood City, California 94063, US
- Founded
- 2014
- Employees
- 1,050
- Programs
- 26
- Drugs
- 28
- Patents
- 36
Revolution Medicines clinical trials
Registry index of 28 ClinicalTrials.gov studies linked to Revolution Medicines programs — each row shows trial ID, program name, phase, status, and indication.
Revolution Medicines trial registry — 28 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Revolution Medicines.
-
RMC-6291-001 — Phase 1
Clinical update -
RMC-LUNG-101C — Phase 2
Clinical update -
RMC-LUNG-101B — Phase 1
Clinical update -
RMC-LUNG-101A — Phase 1
Clinical update -
RMC-6291-101 — Phase 1
Clinical update -
RMC-6236-302 — Phase 3
Clinical update -
RMC-6236-301 — Phase 3
Clinical update -
RMC-6291 — Phase 1
Clinical update
Trial registry
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ - 2024-511548-19-00CTIS ↗
RMC-6291-001
Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor, Colorectal Cancer (CRC)
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CTIS ↗ - 2025-523495-23-00CTIS ↗
DARAXONRASIB (RMC-6236), DARAXONRASIB (RMC-6236)
Resected Pancreatic Ductal Adenocarcinoma (PDAC)
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗